Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... spanning all medical disciplines, including pathology, microbiology, flow cytometry and pharmacogenomics. Combining comprehensive safety, efficacy and pathology testing from a single lab ...
2009 NOV 30 ... can help improve the current standard of practice in the treatment of HF. About Pharmacogenomics Pharmacogenomics is the study of genetic polymorphisms that underlie individual ...
2009 NOV 1 ... expression are needed." Formento and colleagues published their study in Pharmacogenomics (Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in ...
2009 NOV 9 ... Affymetrix, Inc. (Nasdaq:AFFX) announced that the Institute for Pharmacogenomics and Individualized Therapy (IPIT) at the University of North Carolina in Chapel Hill is ...
2009 NOV 16 ... Biology at M.D. Anderson Cancer Center, Houston, Texas, USA, he is an expert in pharmacogenomics, systems pharmacology, and translational research, with a focus on biomarker ...
2009 NOV 30 ... men and women is now available in Brazil thanks to a distribution agreement announced by pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC. ...
2009 NOV 1 ... are also involved in development of personalized medicine based on pharmacogenetics and pharmacogenomics. Currently, there has been a considerable interest in developing rapid diagnostic ...
2009 NOV 2 ... (about one in four) of physicians have had any type of education in the field known as pharmacogenomics (PGx), and only 10 percent of physicians currently believe they have the necessary ...
2009 NOV 23 ... as well as to identify new targets for the refinement of new treatment such as the pharmacogenomics approach." Caruso and colleagues published their study in Cancer ...
2009 NOV 30 ... will be presented on Tuesday, December 8 from 12-1 PM Pacific Standard Time, hosted by pharmacogenomics research and development innovators PsoriasisDX, pioneers of the world's first genetic ...
2009 NOV 1 ... drugs, including warfarin." Scott and colleagues published their study in Pharmacogenomics (CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing. ...
2009 NOV 16 ... variation in common disease, as well as epigenetic mechanisms. Specific examples from pharmacogenomics are described including warfarin dosage and prediction of abacavir hypersensitivity that ...
2009 NOV 1 ... with colorectal cancer." Zintzaras and colleagues published their study in Pharmacogenomics (MTHFR gene polymorphisms and response to chemotherapy in colorectal cancer: a ...
2009 NOV 1 ... warfarin therapy." Sasaki and colleagues published their study in Pharmacogenomics (Warfarin-dosing algorithm based on a population pharmacokinetic/pharmacodynamic model ...
2009 NOV 1 ... taxanes and bevacizumab." Coltelli and colleagues published their study in Pharmacogenomics (Discordant somatic and germline VEGF-A genotype in a cancer patient resistant to ...
2009 NOV 1 ... should improve drug use." Consoli and colleagues published their study in Pharmacogenomics (ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients. ...
